INO Inovio Pharmaceuticals beats Q4 2025 earnings estimates by wide margin shares gain 132 percent today RLJ RLJ Q1 earnings crush estimates by 2519 as cost controls offset slight revenue decline The opportunity most miss about Sterling Infrastructure STRL Investor Concern 20260508 What Biz First BFST disclosed about refinancing plans Q1 2026 Better Than Expected